Compass Therapeutics, Inc. (CMPX)

Typically moves ±6.41% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Compass Therapeutics, Inc. (CMPX) has reported earnings 15 times since Nov 01, 2021. The stock moves an average of ±6.41% the day after reporting, closing higher 60.0% of the time. Its largest post-earnings gain was +31.79% (Nov 01, 2021) and its largest decline was -6.4% (Nov 09, 2023). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How CMPX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.41%

Positive %

60.0%

Negative %

40.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 06, 2026	☀ PRE	+5.84%	open_in_new
May 05, 2026	☀ PRE	+1.55%	open_in_new
Mar 05, 2026	☀ PRE	-2.81%	open_in_new
Nov 05, 2025	☀ PRE	+0.79%	open_in_new
Aug 11, 2025	☀ PRE	+23.7%	open_in_new
May 08, 2025	☀ PRE	+1.14%	open_in_new
Feb 27, 2025	☀ PRE	-1.68%	open_in_new
Nov 12, 2024	☀ PRE	-5.79%	open_in_new
Aug 12, 2024	☀ PRE	+3.67%	open_in_new
May 13, 2024	☀ PRE	-2.5%	open_in_new
Mar 21, 2024	☀ PRE	+5.66%	open_in_new
Nov 09, 2023	☀ PRE	-6.4%	open_in_new
Aug 03, 2023	☀ PRE	+1.53%	open_in_new
May 04, 2023	☀ PRE	-1.33%	open_in_new
Nov 01, 2021	☽ POST	+31.79%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.41%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 24 →

Funds holding

$68202242

Total value held

Buying

19 added · 5 reduced

Blackrock, Inc.

$24707100 +18.68%

State Street Corp

$21798500 +48.67%

Goldman Sachs Group Inc

$7732890 +76.96%

Northern Trust Corp

$2498603 +8.81%

Blackstone Inc.

$1970860 NEW BUY

SEC Filing Types

description SCHEDULE 13G/A

description SCHEDULE 13G

8 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G	20260807	open_in_new SEC.gov
10-Q	20260806	open_in_new SEC.gov
8-K	20260806	open_in_new SEC.gov
8-K	20260701	open_in_new SEC.gov
8-K	20260623	open_in_new SEC.gov
8-K	20260611	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
10-Q	20260505	open_in_new SEC.gov
8-K	20260505	open_in_new SEC.gov

Frequently asked about CMPX earnings

When does Compass Therapeutics, Inc. report earnings next? expand_more

Compass Therapeutics, Inc. (CMPX)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CMPX stock move after earnings? expand_more

Over 15 reports, CMPX has moved an average of ±6.41% the session after earnings, closing higher 60.0% of the time.

What was CMPX's biggest post-earnings move? expand_more

CMPX's largest post-earnings gain on record was +31.79% on Nov 01, 2021, and its largest decline was -6.4% on Nov 09, 2023.

Where can I find Compass Therapeutics, Inc.'s SEC filings? expand_more

All of Compass Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.